RankAlpha logo
Back to Rankings

BMY

Bristol-Myers SquibbB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Successful late-stage readouts or favorable regulatory outcomes plus stable core product sales drive multiple expansion toward the analyst high; acquisition or clearer long-term guidance could lift the stock to the bull target.
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-10-29 · BMO.
What can break
Clinical trial failure or delay
Momentum
67
Value
67
Sentiment
45
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $57.68 · Bull $68.00 · Bear $37.00Analysis 2026-02-06; returns require an exact persisted reference.
Earnings
2026-10-29 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-06 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $65.30
Why
Momentum67 · Δ7d +10.7
Value67 · Δ7d -0.4
Sentiment45 · Δ7d -1.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Next scheduled catalyst: earnings 2026-10-29 · BMO.
  • • Value remains the lead driver in the composite, 7D delta -0.4.

Contradictions & invalidation

  • • Clinical trial failure or delay
  • • Lower-than-expected sales or guidance
  • • Clinical failures, regulatory setbacks, accelerated generic/biosimilar erosion, or weaker guidance could push sentiment down to the bear target; litigation losses or margin pressure would deepen downside.

Catalyst clock

2026-10-29 · BMO

Quarterly earnings and updated 2026 guidance

Lead driver: Value · See fundamentals
Momentum
67
8% active weight
Current posture
7d trendImproving
Δ7d
+10.7
Δ21d
+19.3
Value
67
47% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.7
Sentiment
45
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.8
Δ21d
-8.1
Why this grade

Composite grade B. Momentum 67.4 / Value 66.8 / Sentiment 45.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-06. Scenario method

B+
Bull case
20%
Probability
Target price
$68.00
Analysis reference price unavailable
Analysis 2026-02-06 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$57.68
Analysis reference price unavailable
Analysis 2026-02-06 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$37.00
Analysis reference price unavailable
Analysis 2026-02-06 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$125.59B
Beta
0.29
Shares Out
2.04B
P/E (TTM)
17.9
P/S (TTM)
2.25
P/FCF (TTM)
10.49
Rev YoY
+5.8%
EPS YoY
+152.0%
Gross Margin
+66.6%
Op Margin
+32.4%
Net Debt
$36.47B
Current Ratio
1.53
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data